Apple is taking a bold leap into the future of accessibility and human-computer interaction with its upcoming mind-control feature for iPhones, iPads, and other devices. Expected to launch by the end of 2025, the technology will allow users to control Apple devices using only their thoughts—thanks to a brain-computer interface (BCI) developed in partnership with neurotech startup Synchron.
Stentrode, An Implantable BCI Device
At the heart of this breakthrough is Synchron’s Stentrode, an implantable BCI device. Unlike invasive implants that require open-brain surgery, the Stentrode is inserted through the jugular vein and positioned near the brain’s motor cortex. This minimally invasive approach makes the technology far more accessible and safer for a wider range of patients, according to the Wall Street Journal.
Once implanted, the Stentrode uses 16 electrodes to detect neural signals related to movement. These signals are wirelessly transmitted and processed to translate specific thought patterns into digital commands. For instance, imagining a hand movement could trigger navigation on an iPhone or select an app on an iPad.
Will Be Integrated With the Switch Control framework
This technology is being designed with accessibility in mind. Apple is expected to integrate BCI support into its existing Switch Control framework, which already enables users with motor impairments to interact with devices using joysticks, buttons, and other adaptive equipment. With BCI integration, users could potentially scroll, click, or type—without lifting a finger.
Real-world trials have already shown promising results. One patient with ALS (a condition that causes loss of motor function) has reportedly been able to use devices like the Apple Vision Pro through thought commands alone. While the process is currently slower than traditional input methods, the early success is a major milestone in assistive technology.
Non-Invasive BCI Technology
Apple’s strategy mirrors its earlier Made for iPhone hearing aid initiative, which helped set a Bluetooth communication standard for hearing aids. The company now seems poised to do the same with non-invasive BCI technology, potentially establishing a new industry benchmark.
Unlike Neuralink, which uses a more invasive chip with over 1,000 electrodes embedded in brain tissue, Apple and Synchron’s approach emphasizes safety and accessibility over fine-grain control.
As Apple continues to blur the line between the brain and the digital world, this new mind-control feature could transform the way users with severe physical limitations engage with technology—unlocking new levels of independence and connectivity.
